Literature DB >> 3741202

Blepharospasm with basal ganglia lesions.

J Jankovic.   

Abstract

Entities:  

Mesh：

Year:  1986        PMID： 3741202     DOI： 10.1001/archneur.1986.00520090006004

Source DB:  PubMed          Journal:  Arch Neurol        ISSN： 0003-9942


× No keyword cloud information.
  9 in total

1.  Lesions of basal ganglia due to disulfiram neurotoxicity.

Authors:  D Laplane; N Attal; B Sauron; A de Billy; B Dubois
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-10       Impact factor: 10.154

Review 2.  Secondary blepharospasm associated with structural lesions of the brain.

Authors:  M A Khooshnoodi; S A Factor; H A Jinnah
Journal:  J Neurol Sci       Date:  2013-06-06       Impact factor: 3.181

3.  Efficacy and Safety of Long-Term Therapy with Type A Botulinum Toxin in Patients with Blepharospasm.

Authors:  Francisco Vivancos-Matellano; Ana Rodríguez-Sanz; Yolanda Herrero-Infante; Javier Mascías-Cadavid
Journal:  Neuroophthalmology       Date:  2018-11-26

Review 4.  Cranial dystonia, blepharospasm and hemifacial spasm: clinical features and treatment, including the use of botulinum toxin.

Authors:  S P Kraft; A E Lang
Journal:  CMAJ       Date:  1988-11-01       Impact factor: 8.262

Review 5.  Botulinum toxin in the treatment of muscle specific Oro-facial pain: a literature review.

Authors:  C Sunil Dutt; Pooja Ramnani; Deepak Thakur; Manish Pandit
Journal:  J Maxillofac Oral Surg       Date:  2014-09-04

6.  Blepharospasm: a review of 264 patients.

Authors:  F Grandas; J Elston; N Quinn; C D Marsden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-06       Impact factor: 10.154

7.  Medical Cannabis, a Beneficial High in Treatment of Blepharospasm? An Early Observation.

Authors:  Phillip M Radke; Ali Mokhtarzadeh; Michael S Lee; Andrew R Harrison
Journal:  Neuroophthalmology       Date:  2017-07-18

8.  Beneficial effect of botulinum A toxin in blepharospasm: 16 months' experience with 16 cases.

Authors:  S Maurri; S Brogelli; G Alfieri; F Barontini
Journal:  Ital J Neurol Sci       Date:  1988-08

Review 9.  Treatment of Blepharospasm and Oromandibular Dystonia with Botulinum Toxins.

Authors:  Travis J W Hassell; David Charles
Journal:  Toxins (Basel)       Date:  2020-04-22       Impact factor: 4.546
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.